GraMedica® Brings Life-Changing Foot & Ankle Treatments to South America
Global orthopedic medical device company, GraMedica®, reaches out to multiple locations in an effort to bring education and training to foot and ankle specialists around the world.
On his journey, he will be making stops in the following locations:
• Mexico City, Mexico May 27 – May 30
• Panama City, Panama May 30 – June 3
• Bogota, Columbia June 3 – June 7
• Santiago, Chile June 7 – June 12
• Lima, Peru June 12 – June 14
“Our efforts do not stop in South America,” explains Hoffmann, “we have begun a search for distributors in Thailand, Indonesia, the Philippines, Laos, Cambodia, Myanmar, and South Korea.”
Medical device distributors and foot and ankle specialists interested in working with GraMedica® are welcome to contact Al Hoffmann at firstname.lastname@example.org or 1-888-566-6459.
GraMedica® is a global orthopedic medical device company and leader in the development of life-changing foot and ankle products. Founded in 2003, GraMedica® has grown dynamically and now has products available in more than 27 countries. GraMedica®’s products are designed to correct the root problem of medical conditions, not merely treat the symptoms. Recognized for its innovation, the company is the producer of breakthrough products like HyProCure®.
HyProCure®, a Type II Extra-Osseous TaloTarsal Stabilization (EOTTS) device, has become the leading solution for patients suffering with the symptoms and secondary conditions resulting from partial talotarsal dislocation. The condition is a foot imbalance that throws both the foot and the entire body out of alignment. It affects people of all ages and is often the direct or contributing cause of overpronation, bunions, plantar fasciitis, knee pain, hip pain, back pain and even problems in the neck and shoulders.
The device is placed deep into the canalis portion of the sinus tarsi, reestablishing the normal pivot over which the talus (ankle bone) glides, thereby properly realigning the foot and ankle bones and restoring normal function. Via a minimally invasive procedure, the HyProCure® device instantly stabilizes the hindfoot bones, stopping the continued trauma to the foot and body, and even possibly leading to the reversal of associated conditions. HyProCure® represents a real solution for talotarsal displacement and its devastating effects throughout the body.
Foot and ankle surgeons are invited to learn more about the HyProCure® implant and procedure at http://www.GraMedica.com, where they can also train online and/or find a live surgical training seminar in their area.
Potential surgical candidates can find out more about the HyProCure® solution and the devastating effects of talotarsal dislocation at http://www.HyProCure.com.
Manager, International Sales